Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Pfizer Identifier:
First received: November 17, 2006
Last updated: April 5, 2017
Last verified: April 2017
This is a study to collect blood from volunteers to assist in assay development.

Condition Intervention
Healthy Subjects
Procedure: Blood Collection

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Primary Purpose: Diagnostic
Official Title: Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

Further study details as provided by Pfizer:

Primary Outcome Measures:
  • "No outcome measures". Blood collected for assay development. [ Time Frame: 1 hour ]

Estimated Enrollment: 900
Actual Study Start Date: August 2006
Estimated Study Completion Date: December 2017
Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Arm 1 Procedure: Blood Collection
Blood Collection


Ages Eligible for Study:   18 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy Volunteers aged 18-64

Exclusion Criteria:

  • Bleeding disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00401232

United States, Maryland
SNBL Clinical Pharmacology Center
Baltimore, Maryland, United States, 21201
United States, New Jersey
Frontage Clinical Services Inc
Hackensack, New Jersey, United States, 07601
Sponsors and Collaborators
Study Director: Pfizer Call Center Pfizer
  More Information

Additional Information:
Responsible Party: Pfizer Identifier: NCT00401232     History of Changes
Other Study ID Numbers: 6108A1-800
B1971032 ( Other Identifier: Alias Study Number )
Study First Received: November 17, 2006
Last Updated: April 5, 2017 processed this record on April 28, 2017